• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Bellevue Funds Lux - BB Biotech

+ Add to Watchlist

M0U2:GR

315.5900 EUR 4.1500 1.33%

As of 11:20:42 ET on 09/19/2014.

Snapshot for Bellevue Funds Lux - BB Biotech (M0U2)

Open: 311.4400 High - Low: 315.5900 - 311.4400 Primary Exchange: Frankfurt
Volume: 0 52-Week Range: 212.0100 - 315.5900 Beta vs DAX: 0.6649

ETF Chart for M0U2

No chart data available.
  • M0U2:GR 315.3190
  • 1D
  • 1M
  • 1Y
311.4400
Interactive M0U2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for M0U2

Bellevue Funds (Lux) - BB Biotech is an open-end investment fund incorporated in Luxembourg. The Fund's objective is long-term capital appreciation. The Fund invests mainly in equities and equity related securities of companies that are directly involved in the biotechnology sector. The focus is on companies that develop, research, and market various technologies and products in this sector.

Inception Date: 2009-03-31 Telephone: 41-44-267-67-00
Managers: DANIEL KOLLER
Web Site: www.bellevuegroup.com

Fundamentals for M0U2

NAV -
Assets (M) (on 2014-09-18) 54.3320
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium -
Average 52-Week % Premium -
Fund Leveraged N

Dividends for M0U2

No dividends reported

Performance for M0U2

1-Month +7.92% 1-Year +36.93%
3-Month +20.70% 3-Year +42.23%
Year To Date +32.38% 5-Year -
Expense Ratio -

Top Fund Holdings for M0U2

Filing Date: 08/29/2014
Name Position Value % of Total
Gilead Sciences Inc 49,526 5,328,007 9.815%
Celgene Corp 54,964 5,222,679 9.620%
Biogen Idec Inc 13,947 4,784,379 8.813%
Amgen Inc 18,766 2,615,605 4.818%
Alexion Pharmaceuticals Inc 15,146 2,564,066 4.723%
Regeneron Pharmaceuticals Inc 6,795 2,381,783 4.387%
Vertex Pharmaceuticals Inc 25,071 2,345,893 4.321%
Incyte Corp 36,352 1,970,278 3.629%
Medivation Inc 19,346 1,765,516 3.252%
Isis Pharmaceuticals Inc 38,893 1,585,279 2.920%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil